Apogee Enterprises (APOG) Misses Q4 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts APOG Hot Sheet
Price: $42.97 --0%
EPS Growth %: -35.7%
Financial Fact:
Income tax benefit: 10.97M
Today's EPS Names:
VAXX, NMRD, EGRX, More
EPS Growth %: -35.7%
Financial Fact:
Income tax benefit: 10.97M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Apogee Enterprises (NASDAQ: APOG) reported Q4 EPS of $0.89, $0.03 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $345.69 million versus the consensus estimate of $336.11 million.
GUIDANCE:
Apogee Enterprises sees FY2026 EPS of $3.55-$4.11, versus the consensus of $4.94.
For earnings history and earnings-related data on Apogee Enterprises (APOG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Arcos Dorados (ARCO) Tops Q2 EPS by 7c
- BK Technologies (BKTI) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
